Does METOPROLOL Cause Mobility decreased? 154 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 154 reports of Mobility decreased have been filed in association with METOPROLOL (metoprolol succinate). This represents 0.4% of all adverse event reports for METOPROLOL.
154
Reports of Mobility decreased with METOPROLOL
0.4%
of all METOPROLOL reports
5
Deaths
101
Hospitalizations
How Dangerous Is Mobility decreased From METOPROLOL?
Of the 154 reports, 5 (3.2%) resulted in death, 101 (65.6%) required hospitalization, and 6 (3.9%) were considered life-threatening.
Is Mobility decreased Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for METOPROLOL. However, 154 reports have been filed with the FAERS database.
What Other Side Effects Does METOPROLOL Cause?
Drug ineffective (3,434)
Dyspnoea (3,428)
Dizziness (3,275)
Hypotension (3,213)
Completed suicide (2,959)
Fatigue (2,784)
Off label use (2,580)
Toxicity to various agents (2,404)
Bradycardia (2,024)
Nausea (1,894)
What Other Drugs Cause Mobility decreased?
ADALIMUMAB (8,829)
ETANERCEPT (8,321)
METHOTREXATE (5,936)
ABATACEPT (4,519)
TOCILIZUMAB (4,403)
LEFLUNOMIDE (4,354)
HYDROXYCHLOROQUINE (4,105)
RITUXIMAB (4,067)
INFLIXIMAB (3,784)
TOFACITINIB (3,734)
Which METOPROLOL Alternatives Have Lower Mobility decreased Risk?
METOPROLOL vs METRELEPTIN
METOPROLOL vs METRONIDAZOLE
METOPROLOL vs METRONIDAZOLE\METRONIDAZOLE
METOPROLOL vs METYRAPONE
METOPROLOL vs MEXILETINE